https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2017-10-24 / Sci Rep 2017 10;7(1):13902
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2017-10-24 / Sci Rep 2017 10;7(1):139022017-10-24 00:00:002021-11-15 20:01:44Immunotherapy with subcutaneous immunogenic autologous tumor lysate increases murine glioblastoma survival
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2017-07-19 / Int J Cancer 2017 11;141(9):1891-1900
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2017-07-19 / Int J Cancer 2017 11;141(9):1891-19002017-07-19 00:00:002021-11-15 20:03:02Characterization of PD-1 upregulation on tumor-infiltrating lymphocytes in human and murine gliomas and preclinical therapeutic blockade
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
IOZK
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
IOZK2017-07-10 11:44:412019-07-15 16:57:22IOZK Artikel im International Journal of Molecular Sciences von Prof. Schirrmacher über die Rolle des Newcastle Disease Virus im Rahmen der Tumorimpfung,
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2017-05-20 / Int J Mol Sci 2017 May;18(5)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2017-05-20 / Int J Mol Sci 2017 May;18(5)2017-05-20 00:00:002021-11-15 16:51:51Immunobiology of Newcastle Disease Virus and Its Use for Prophylactic Vaccination in Poultry and as Adjuvant for Therapeutic Vaccination in Cancer Patients
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
IOZK
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
IOZK2017-05-01 11:52:062019-02-10 12:10:59IOZK Artikel von Prof. Schirrmacher in „Deutsche Zeitschrift für Onkologie“ über die Grundlagen der Immuntherapie
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2017-04-27 / Sci Rep 2017 04;7(1):1217
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2017-04-27 / Sci Rep 2017 04;7(1):12172017-04-27 00:00:002021-11-15 20:07:45Sensitization of glioblastoma tumor micro-environment to chemo- and immunotherapy by Galectin-1 intranasal knock-down strategy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
IOZK
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
IOZK2017-03-01 12:12:242020-05-27 11:24:21IOZK Artikel im Austin Oncology Case Reports über Krebsimpfstoffe
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2017-01-21 / J Neurooncol 2017 04;132(2):255-266
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2017-01-21 / J Neurooncol 2017 04;132(2):255-2662017-01-21 00:00:002021-11-15 20:06:08Development of the SIOPE DIPG network, registry and imaging repository: a collaborative effort to optimize research into a rare and lethal disease
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
IOZK
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
IOZK2016-08-10 12:33:022020-05-27 11:26:48Artikel von Prof Schirrmacher in Biomedicines: „Fifty Years of Clinical Application of Newcastle Disease Virus“
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
IOZK
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
IOZK2016-05-01 13:48:072019-02-12 13:48:48Veröffentlichung von Stefaan Van Gool MD. PhD.: Electroporation of Dendritic Cells with WT1, Survivin, and TriMix
